Equities

Indiva Ltd

Indiva Ltd

Actions
  • Price (CAD)0.09
  • Today's Change0.00 / 0.00%
  • Shares traded74.08k
  • 1 Year change+20.00%
  • Beta1.1301
Data delayed at least 15 minutes, as of Mar 28 2024 16:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound.

  • Revenue in CAD (TTM)36.01m
  • Net income in CAD-6.94m
  • Incorporated1979
  • Employees142.00
  • Location
    Indiva Ltd333 Preston Street, Suite 710OTTAWA K1S 5N4CanadaCAN
  • Phone+1 (613) 883-8541
  • Fax+1 (613) 883-8541
  • Websitehttps://indiva.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AEterna Zentaris Inc.9.31m-31.70m13.73m21.00--0.385--1.47-6.53-6.531.927.340.12581.3314.77443,317.90-42.84-18.92-47.26-22.2696.8287.90-340.56-90.719.89--0.0082--7.2243.62-171.59--22.42--
Resverlogix Corp0.00-17.39m15.07m19.00---------0.0646-0.06460.00-0.35690.00----0.00-141.56--------------0.0157-0.8731--------85.43------
Valeo Pharma Inc54.29m-28.43m15.79m100.00------0.2908-0.3255-0.32550.6249-0.47651.233.5312.39434,296.00-64.52-64.35-215.78-113.2221.3823.88-52.37-69.710.2974-1.333.51--94.3165.20-8.01--76.61--
Sirona Biochem Corp34.78k-2.54m16.58m--------476.81-0.0101-0.01010.0001-0.00990.03--4.35---218.98-173.09---383.49-----7,312.22-1,405.28---11.76-----94.82-51.3728.52------
Indiva Ltd36.01m-6.94m17.59m142.00--45.16--0.4886-0.0471-0.04710.23070.0020.93176.599.24---17.96-32.56-29.41-48.7325.2916.88-19.27-74.280.6058-1.010.9833--5.95--27.16---18.11--
Ceapro Inc11.30m-2.70m18.40m12.00--0.614--1.63-0.0345-0.03450.14450.38270.32421.585.81---7.755.61-8.045.9645.1353.80-23.9010.807.72-19.340.0726--9.567.8330.68---38.94--
Data as of Mar 28 2024. Currency figures normalised to Indiva Ltd's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.